Back to Journals » Risk Management and Healthcare Policy » Volume 15

Clinical Risk Factors for Thoracic Ossification of the Ligamentum Flavum: A Cross-Sectional Study Based on Spinal Thoracic Three-Dimensional Computerized Tomography

Authors Zhang H , Deng N, Zhang L , Zhang L, Wang C

Received 9 February 2022

Accepted for publication 9 May 2022

Published 13 May 2022 Volume 2022:15 Pages 1065—1072

DOI https://doi.org/10.2147/RMHP.S361730

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jongwha Chang



Hao Zhang,1,* Nian Deng,2,* Lu Zhang,3 Lei Zhang,4 Chao Wang1

1Department of Spine Surgery, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China; 2Department of Orthopaedics, The Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, People’s Republic of China; 3Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China; 4Department of Orthopaedics, The First Affiliated Hospital of Shandong First Medical University, Jinan, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Chao Wang, Department of Spine Surgery, The Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, 266000, People’s Republic of China, Email [email protected] Lei Zhang, Department of Orthopaedics, The First Affiliated Hospital of Shandong First Medical University, No. 16766 Jingshi Road, Jinan, 266000, People’s Republic of China, Email [email protected]

Background: Inconsistent results of the clinical risk factors associated with thoracic ossification of the ligamentum flavum (TOLF) have been reported in limited previous studies.
Purpose: This retrospective study aimed to investigate the potential risk factors for TOLF by a retrospective cross-sectional study, which may provide valuable experience for further clinical and pathophysiological research.
Methods: A total of 2247 asymptomatic participants, who underwent spinal thoracic three-dimensional computerized tomography (3D-CT) scans at our institution from January 2016 to December 2019, were enrolled in this study according to the screening criteria. Demographic information such as age, sex, height, weight, body mass index (BMI), smoking and drinking history, diastolic blood pressure (DBP), systolic blood pressure (SBP), and pulse pressure (PP) were recorded. Laboratory results included serum low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglyceride (TG), uric acid (UA), creatinine (Cr), calcium, and phosphorus. Participants were divided into TOLF group and non-TOLF group in accordance with the thoracic 3D-CT manifestation.
Results: TOLF was observed in 153 (6.81%) asymptomatic participants. Comparison of demographic data and laboratory examinations between the two groups showed that participants in the TOLF group were older, had a higher BMI, as well as higher levels of DBP. In addition, there was no significant difference in sex, drinking, tobacco use, SBP, TC, TG, PP, and levels of LDL-C, HDL-C, sUA, sCr, calcium, and phosphorus between the two groups. Furthermore, dichotomous logistic regression analyses revealed that age (OR = 1.018, p = 0.041) and BMI (OR = 1.090, p < 0.001) were risk factors for TOLF.
Conclusion: Our study reveals that age and BMI are clinical risk factors for the development of TOLF, while age cannot be identified as an independent risk factor for female in subgroup analysis.

Keywords: ossification of the ligamentum flavum, risk factor, body mass index, uric acid, triglyceride

Introduction

Ossification of the ligamentum flavum (OLF) is a disease mainly affecting the thoracic spine, which is characterized by progressive ectopic ossification of the ligamentum flavum.1 Thoracic OLF (TOLF) often leads to a progressive compression of the spinal cord, the nerve root, or the conus medullaris based on the location of the lesion. In 1920, Polgar first reported that TOLF was closely associated with thoracic myelopathy.2 After that, many reports revealed that TOLF was an important pathogenesis to thoracic spinal canal stenosis and radiculomyelopathy, especially at the lower thoracic spine.3 When progressive and severe symptom with evidence of spinal cord compression is observed, surgical intervention is always required.4

Worldwide, spinal ligament ossification diseases, such as TOLF and ossification of the posterior longitudinal ligament (OPLL), have a higher prevalence in China, Japan, and other eastern Asian countries.5,6 This phenomenon suggests that genetic background is a significant influence factor even though the specific mechanisms beneath are still unclear.7 So far, no consensus has been reached about the etiology and underlying mechanism of TOLF.8 Kaneyama9 and Maigne10 proposed that local mechanical stress, especially rotation strain to the lower thoracic spine, is associated with the development of TOLF. Basic metabolic elements in the microenvironment seemed to play a key role in the development of TOLF.11 Similarly, inflammatory cytokines, such as IL-6 and TNF-α, were also proved to be crucial to OLF through local milieu of the spinal canal.12 Several clinical risk factors are considered associated with OLF, such as age, sex, ethnicity, obesity, ankylosing spondylitis, history of hypertension and diabetes, diffuse skeletal hyperostosis, uric acid, and abnormal metabolism of trace elements.8,13,14 Furthermore, metabolic syndrome and leptin resistance are regarded as risk factors closely related to the process of TOLF.15 Therefore, identifying the risk factors for TOLF is essential for the management of the disease.

To the best of our knowledge, there are few small sample size studies to assess the association between TOLF and clinical risk factors. In the current study, we aimed to investigate significant independent risk factors for TOLF, which mainly included clinical indicators and laboratory examinations.

Materials and Methods

Participant Selection

We conducted a retrospective cross-sectional study based on data from 3399 asymptomatic participants (no neurological symptoms but may be with back pain) who executed thoracic three-dimensional (3D) CT scans as a part of routine health examinations in the Affiliated Hospital of Qingdao University from January 2016 to December 2019. The study was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University. Exclusion criteria were participants with missing clinical indicators (n = 275), missing laboratory examinations (n = 384), participants younger than 50 years old (n = 196), and participants with cancer or infection (n = 297). A total of 2247 asymptomatic participants were included in our analysis. Based on the imaging findings, all participants enrolled in the study were divided into two groups: the TOLF group and the non-TOLF group (Figure 1).

Figure 1 Flowchart of the study participants.

Demographic Data

All participants’ age, sex, blood pressure, height, weight, body mass index (BMI), tobacco use, and history of drinking were recorded and collected. Blood pressure examinations included diastolic blood pressure (DBP), systolic blood pressure (SBP), and pulse pressure (PP). PP is defined as the difference between SBP and DBP.16 The participants’ degree of obesity and body fat were described by BMI. BMI was calculated as follows: BMI = weight/height2 (kg/m2). All participants were asked to take off their shoes and socks and wear light and thin clothes when their height (cm) and weight (kg) were measured.

Laboratory Examinations

Venous blood samples were collected from participants who had been fasting for at least 8 hours. Laboratory measurements included low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglyceride (TG), serum uric acid (sUA), serum creatinine (sCr), serum calcium, and serum phosphorus.

CT Examination

All thoracic CT scans were performed in the supine position with a 128-row MDCT scanner (GE Healthcare, Waukesha, USA). The gantry rotation time is 0.5 s, and tube voltage is 120 kV. Axial images obtained during CT examination were 1mm thick and were reconstructed into sagittal images, coronal images, and 3D images by this system.

Definition of TOLF

TOLF presented as an ossified bridge or mass in the ligamentum flavum between two adjacent laminae on sagittal CT scan. The method of differential diagnosis of TOLF was in accordance with the recommendations of Kim et al.17 The diagnosis of TOLF was based on radiological imaging manifestations, especially 3D CT scans, simultaneously analyzed and confirmed by two experienced spinal surgeons. Any disagreements were settled by discussion with another senior spinal surgeon. We calculated the intraclass correlation coefficient (ICC) to assess the inter-observer and intra-observer reliability by a two-way random effects model, and ICC values for radiographic parameters >0.85.

Statistical Analysis

All analyses were performed using SPSS Statistics software, version 22.0. (SPSS Inc., Chicago, IL, USA). The normality of the distribution of the measurement data was evaluated using the Kolmogorov–Smirnov test. Continuous normally distributed variables are shown as mean ± standard deviation and categorical variables are shown as percentages (%). Student’s t-test was used to compare the clinical continuous variables between the cohorts. The clinical categorical variables were assessed using the chi-square test. The factors with P-values <0.2 selected in Student’s t-test and chi-square test analysis were further incorporated into the dichotomous logistic regression analyses.18 Dichotomous logistic regression analysis (stepwise regression analysis method) was also performed to compute odds ratios and 95% confidence intervals to determine the significant and independent risk factors associated with TOLF. A P-value <0.05 was considered statistically significant.

Results

Demographic Data

A total of 2247 participants (mean age, 67.87 ± 9.71 years; 918 male and 1329 female) were enrolled in the study, including 918 men and 1329 women. A total of 361 (16.07%) participants had a history of tobacco use, 360 (13.80%) participants had a history of drinking. The mean BMI was 24.54 ± 4.01 kg/m2 (range, 13.06–45.72 kg/m2), the mean sUA was 291.09 ± 92.56 μmol/L (range, 54.2–1034.9 μmol/L). The mean TC was 4.87 ± 1.18 mmol/l (range, 1.38–16.04 mmol/l). The mean TG was 1.41 ± 1.16 mmol/l (range, 0.2–28.87 mmol/l). The demographic data and clinical findings of the included participants are presented in Table 1.

Table 1 Demographic Data of All Participants

Comparison Between the TOLF and Non-TOLF Groups

Asymptomatic TOLF was observed in 153 (6.81%) participants, and 2094 participants were enrolled in the non-TOLF group. In the TOLF group, 21 (13.73%) participants had a history of tobacco use, and 20 (13.07%) had a history of drinking. Comparison between the two groups showed that participants in the TOLF group were older (69.31 ± 8.82 vs 67.77 ± 9.77 years, p = 0.040), had a higher BMI (26.00 ± 3.46 vs 24.43 ± 4.03 kg/m2, p < 0.001), as well as a higher level of DBP (83.23 ± 11.92 vs 79.31 ± 11.92 mmHg, p < 0.001). In addition, there was no significant difference in sex, drinking, tobacco use, SBP, TC, TG, PP, and levels of LDL-C, HDL-C, sUA, sCr, calcium, and phosphorus between the two groups (Table 2).

Table 2 Comparison Between Non-TOLF Group and TOLF Group

Risk Factors

The results of dichotomous logistic regression analyses revealed that age (odds ratio [OR] = 1.018, p = 0.041), and BMI (OR = 1.090, p < 0.001), were independent risk factors associated with TOLF. The results of the dichotomous logistic regression analyses are shown in Table 3.

Table 3 Binary Logistic Regression Analysis Risk Factors for TOLF

Subgroup Analysis

Univariate regression analysis of subgroups showed that BMI of participants with TOLF was significantly higher in both male and female (Table 4). Multivariate regression analysis of subgroups showed that BMI was also significant (Table 5). In addition, the results of dichotomous logistic regression analyses revealed that age (OR = 1.031, p = 0.02) were also significant risk factors associated with TOLF in male.

Table 4 Comparison of Biochemical and Clinical Parameters Between Participants with and without TOLF in Subgroups

Table 5 Binary Logistic Regression Analysis Risk Factors for TOLF in Subgroups

Discussion

Both OLF and OPLL are in a cluster of systematic ossification of the spinal ligaments and have high rates of prevalence in Eastern Asia, particularly in Japan.1 Mori et al5 reported that the incidence of TOLF in Japanese population was as high as 36%. Therefore, OLF was once termed as “Japanese disease”.19 In our study, TOLF accounts for 6.81% of all asymptomatic participants, which is lower than most previous reports but higher than 3.8% in Southern Chinese population using magnetic resonance imaging.2,5,20,21 This may be a consequence of regional divergence and different modalities used in diagnosis. Limited studies attempted to reveal the clinical risk factors for TOLF. Kim et al8 utilized chest CT as the screening method of TOLF for 4999 individuals in Korea and found that after logistic regression analysis, gender and thoracic kyphosis were significantly related to TOLF. There are several distinctions between Kim’s and our studies. Kim et al adopted a different age range (younger than 20 years old) from our study (younger than 50 years old) in exclusion criteria. Even though patients in both studies were free from neurological deficits, the individuals in the two studies seeking for different radiological examinations because of disparate symptoms (back versus pulmonary symptoms). The results of collected data obtained from distinctive population backgrounds may then vary. Therefore, the conclusions should be determined in a limited and specific condition.

Our dichotomous logistic regression analyses indicate that age is positively correlated with TOLF. OLF is regarded as a presentation of degenerative changes in the spinal column due to aging.1 The incidence of OLF positively increases with age has also been reported in previous studies.2,22 Park et al23 reported that degeneration mainly affected the local milieu, and then induced ossification of human ligamentum flavum cells. Lang et al20 reported that TOLF was more frequently observed in the lower thoracic regions and its prevalence increased with age. Thus, age and associated degenerative factors seemed to play important roles in the development of TOLF. Unlike Kim’s conclusion that gender was correlated with TOLF, no statistical difference in gender was observed between the TOLF and non-TOLF groups in our study. A previous study utilizing gender-stratified risk factor analysis showed that aging had a negative impact on TOLF in female.17 In the present study, age was identified as a risk factor of TOLF in all participants, but not as an independent risk factor in the subgroup of female. That means it is yet to reach a consensus in the correlation between age and TOLF in female. Therefore, further epidemiologic studies are warranted to demonstrate the potential correlation.

BMI was closely associated with TOLF in the total population or subgroup analyses. Fan et al15 demonstrated that leptin was critically associated with obesity and the pathological development of TOLF. It is not clear that how obesity contributes to TOLF, but some researchers believe that hyperleptinemia and the STAT3 signaling pathway play important roles in the pathogenesis of TOLF.15 Leptin was identified as an adipocyte-derived cytokine that can stimulate the osteogenic differentiation of ligament cells. In addition, hyperleptinemia is a common feature of obese people, and its synthesis and secretion are significantly increased in obese people.24 In addition, leptin receptors were expressed but showed different osteogenic effects in both TOLF and non-TOLF cells. Therefore, they confirmed STAT3 as a critical molecule in mediating leptin-stimulated cell osteogenesis in TOLF.15

In the present study, TC and TG were not identified as risk factors in dichotomous logistic regression analysis. In addition, there was no significantly different in TC and TG of participants between the TOLF group and the non-TOLF group. However, the results were not all the same in previous researches, and there may be some differences upon pathological mechanisms between TOLF and OPLL. A retrospective study collecting 1789 asymptomatic subjects who underwent whole-body CT scans showed that subjects with OPLL had higher levels of TG than subjects without OPLL.13 Banks et al25 suggested that triglycerides could truly inhibit leptin transport across the blood–brain barrier, inducing receptor resistance to leptin and insulin. In addition, leptin and insulin resistance can promote further obesity and lead to a vicious cycle. But hypertriglyceridemia does not necessarily mean obesity. Thus, further studies are needed to confirm the possibility of interactions among TOLF, obesity, and TG.

Some metabolic markers were once reported or predicted to affect the process of TOLF.26 Li et al used metabolomics and transcriptomics to identify the molecular mechanism and diagnostic biomarkers in TOLF, and the result shows that uric acid might be the potential biomarker for TOLF and play an important role in the detailed pathway.27 However, there were only 25 patients with TOLF and 23 healthy volunteers included in the research. Thus, the relatively small sample size may cause bias of result. Different from the previous research, the result of the present study show that uric acid levels do not influence the incidence of TOLF. Matsui et al28 reported that the increased content of calcium in the ligament flavum was associated with overloaded stress on the spine and the development of ossification. Wang et al11 reported that calcium and phosphorus content tended to increase in OLF specimens, and phosphorus content in serum was also significantly higher in participants with TOLF. However, as the study sample size is small, the conclusions are not convincing enough. Although previous studies documented that calcium was closely associated with elastin and could stimulate osteoblast-like cells with enhanced expression of c-jun and c-fos,29 the calcium or phosphorus content in the tissue of OLF may not be correlated with that in the serum. Therefore, it is comprehensible that the serum calcium and serum phosphorus did not show significant differences between the TOLF and non-TOLF groups in the present study.

Limitations

There are some limitations of the study that must be noted. First, we did not have detailed information on some important metabolic indicators, such as glycosylated hemoglobin, thyroid hormone, 25-hydroxyvitamin D, and osteocalcin. Those metabolic indicators were not detected routinely for most individuals. Therefore, some potential risk factors may be neglected. Second, although the stringent excluding criteria was adopted, the participants with subtle clinical symptoms cannot be distinguished from asymptomatic participants. Finally, the number of participants enrolled in the present study was relatively small. Therefore, further large-sample epidemiological data and more comprehensive laboratory indicators are needed.

Conclusions

Our study shows that age and BMI are clinical risk factors associated with TOLF in older adults with or without back pain, while age cannot be identified as an independent risk factor for female in subgroup analysis.

Ethics and Consent

All procedures were performed in compliance with the Declaration of Helsinki and were approved by the Ethics Committee of the Affiliated Hospital of Qingdao University. All patients involved gave written informed consent to review their medical records. All personal details were erased before analysis to cover patient data confidentiality.

Acknowledgments

This work was supported by grants from National Natural Science Foundation of China (No.81902209), China Postdoctoral Science Foundation (No.2020M672002), the Shandong Key Research and Development Plan (2019GSF107057), and Academic Promotion Program of Shandong First Medical University (grant number:2019LJ001). Hao Zhang and Nian Deng are co-first authors for this study.

Disclosure

The authors declare no relevant financial, personal, political, intellectual or religious conflicts of interests for this work.

References

1. Hirabayashi S. Ossification of the ligamentum flavum. Spine Surg Relat Res. 2017;1(4):158–163. doi:10.22603/ssrr.1.2016-0031

2. Guo JJ, Luk KD, Karppinen J, Yang H, Cheung KM. Prevalence, distribution, and morphology of ossification of the ligamentum flavum: a population study of one thousand seven hundred thirty-six magnetic resonance imaging scans. Spine. 2010;35(1):51–56. doi:10.1097/BRS.0b013e3181b3f779

3. Kim JK, Ryu HS, Moon BJ, Lee JK. Clinical outcomes and prognostic factors in patients with myelopathy caused by thoracic ossification of the ligamentum flavum. Neurospine. 2018;15(3):269–276. doi:10.14245/ns.1836128.064

4. Wu D, Wang H, Hu P, Xu W, Liu J. The postoperative prognosis of thoracic ossification of the ligamentum flavum can be described by a novel method: the thoracic ossification of the ligamentum flavum score. World Neurosurg. 2019;130:e47–e53. doi:10.1016/j.wneu.2019.05.185

5. Mori K, Kasahara T, Mimura T, et al. Prevalence, distribution, and morphology of thoracic ossification of the yellow ligament in Japanese: results of CT-based cross-sectional study. Spine. 2013;38(19):E1216–E1222. doi:10.1097/BRS.0b013e31829e018b

6. Aizawa T, Sato T, Sasaki H, Kusakabe T, Morozumi N, Kokubun S. Thoracic myelopathy caused by ossification of the ligamentum flavum: clinical features and surgical results in the Japanese population. J Neurosurg Spine. 2006;5(6):514–519. doi:10.3171/spi.2006.5.6.514

7. Liu Y, Zhao Y, Chen Y, Shi G, Yuan W. RUNX2 polymorphisms associated with OPLL and OLF in the Han population. Clin Orthop Relat Res. 2010;468(12):3333–3341. doi:10.1007/s11999-010-1511-5

8. Kim SI, Ha KY, Lee JW, Kim YH. Prevalence and related thoracic ossification of the ligamentum flavum-a computed tomography-based cross-sectional study. Spine J. 2018;18(4):551–557. doi:10.1016/j.spinee.2017.08.240

9. Kaneyama S, Doita M, Nishida K, et al. Thoracic myelopathy due to ossification of the yellow ligament in young baseball pitchers. J Spinal Disord Tech. 2008;21(1):68–71. doi:10.1097/BSD.0b013e31811dfc2d

10. Maigne JY, Ayral X, Guérin-Surville H. Frequency and size of ossifications in the caudal attachments of the ligamentum flavum of the thoracic spine. Role of rotatory strains in their development. An anatomic study of 121 spines. Surg Radiol Anat. 1992;14(2):119–124. doi:10.1007/bf01794886

11. Wang Z, Li XD, Li MQ, Wang QP. Changes in basic metabolic elements associated with the degeneration and ossification of ligamenta flava. J Spinal Cord Med. 2008;31(3):279–284. doi:10.1080/10790268.2008.11760723

12. Ren L, Hu H, Sun X, Li F, Zhou JJ, Wang YM. The roles of inflammatory cytokines in the pathogenesis of ossification of ligamentum flavum. Am J Transl Res. 2013;5(6):582–585.

13. Oshima Y, Doi T, Kato S, et al. Association between ossification of the longitudinal ligament of the cervical spine and arteriosclerosis in the carotid artery. Sci Rep. 2020;10(1):3369. doi:10.1038/s41598-020-60248-3

14. Doi T, Sakamoto R, Horii C, et al. Risk factors for progression of ossification of the posterior longitudinal ligament in asymptomatic subjects. J Neurosurg Spine. 2020:1–7. doi:10.3171/2020.3.Spine2082

15. Fan D, Chen Z, Chen Y, Shang Y. Mechanistic roles of leptin in osteogenic stimulation in thoracic ligament flavum cells. J Biol Chem. 2007;282(41):29958–29966. doi:10.1074/jbc.M611779200

16. Tang KS, Medeiros ED, Shah AD. Wide pulse pressure: a clinical review. J Clin Hypertens. 2020;22(11):1960–1967. doi:10.1111/jch.14051

17. Kim SI, Ha KY, Lee JW, Kim YH. Prevalence and related clinical factors of thoracic ossification of the ligamentum flavum-a computed tomography-based cross-sectional study. Spine J. 2018;18(4):551–557. doi:10.1016/j.spinee.2017.08.240

18. Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/jco.2007.12.9791

19. Celli P, Caroli E, Trillò G, Ferrante L. Ossification of the ligamentum flavum in a Caucasian. Case report. J Neurosurg Sci. 2002;46(2):96–99; discussion 99.

20. Lang N, Yuan HS, Wang HL, et al. Epidemiological survey of ossification of the ligamentum flavum in thoracic spine: CT imaging observation of 993 cases. Eur Spine J. 2013;22(4):857–862. doi:10.1007/s00586-012-2492-8

21. Liang H, Liu G, Lu S, et al. Epidemiology of ossification of the spinal ligaments and associated factors in the Chinese population: a cross-sectional study of 2000 consecutive individuals. BMC Musculoskelet Disord. 2019;20(1):253. doi:10.1186/s12891-019-2569-1

22. Ergun T, Lakadamyali H. The relationship between the prevalance and size of lumbar ossified ligamentum flavum and the presence and degree of facet joint degeneration. Eur J Radiol. 2012;81(11):3456–3460. doi:10.1016/j.ejrad.2012.05.009

23. Park JO, Lee BH, Kang YM, et al. Inflammatory cytokines induce fibrosis and ossification of human ligamentum flavum cells. J Spinal Disord Tech. 2013;26(1):E6–E12. doi:10.1097/BSD.0b013e3182698501

24. Shirakura Y, Sugiyama T, Tanaka H, Taguchi T, Kawai S. Hyperleptinemia in female patients with ossification of spinal ligaments. Biochem Biophys Res Commun. 2000;267(3):752–755. doi:10.1006/bbrc.1999.2027

25. Banks WA, Farr SA, Salameh TS, et al. Triglycerides cross the blood-brain barrier and induce central leptin and insulin receptor resistance. Int J Obes. 2018;42(3):391–397. doi:10.1038/ijo.2017.231

26. Miyamoto S, Yonenobu K, Ono K. Elevated plasma fibronectin concentrations in patients with ossification of the posterior longitudinal ligament and ossification of the ligamentum flavum. Spine. 1993;18(15):2267–2270. doi:10.1097/00007632-199311000-00021

27. Li J, Yu L, Guo S, Zhao Y. Identification of the molecular mechanism and diagnostic biomarkers in the thoracic ossification of the ligamentum flavum using metabolomics and transcriptomics. BMC Mol Cell Biol. 2020;21(1):37. doi:10.1186/s12860-020-00280-3

28. Matsui H, Katoh Y, Tsuji H. Untreated hypophosphatemic vitamin D-resistant rickets with symptomatic ossification of the ligamentum flavum. J Spinal Disord. 1991;4(1):110–113.

29. Muthukumar N. Ossification of the ligamentum flavum as a result of fluorosis causing myelopathy: report of two cases. Neurosurgery. 2005;56(3):E622; discussion E622. doi:10.1227/01.NEU.0000154062.14313.6D

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.